Vladimir Andelkovic

8 papers receiving 89 citations

Peers

Vladimir Andelkovic
Comparison fields: 5 of 33
  • Pulmonary and Respiratory Medicine 55
  • Oncology 46
  • Molecular Biology 39
  • Pathology and Forensic Medicine 20
  • Cancer Research 11
Replace Mark Mayeda with:
Mark Mayeda United States
Laura Monovich United States
Adrián Cuevas-Bourdier Spain
Ludovic Bigot France
Hadassa Hirschfield United States
T. Y. Kim South Korea
Bianca J. Lee United States
Ippokratis Korantzis Greece
Hoi-Lam Ngan Hong Kong
Sara Benlloch United Kingdom
Vladimir Andelkovic relative to Mark Mayeda United States Mark Mayeda's profile →
Citations per field
00.5×5.3×
Mark Mayeda · 1×
Citations per year

Countries citing papers authored by Vladimir Andelkovic

Since Specialization
Citations

This map shows the geographic impact of Vladimir Andelkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Andelkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Andelkovic more than expected).

Fields of papers citing papers by Vladimir Andelkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Andelkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Andelkovic. The network helps show where Vladimir Andelkovic may publish in the future.

Co-authorship network of co-authors of Vladimir Andelkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Andelkovic. A scholar is included among the top collaborators of Vladimir Andelkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Andelkovic. Vladimir Andelkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 0
5 2
6 6
7 73
8
Pembrolizumab for Metastatic Melanoma: Results of the Complete Responders On the Named Patient Access Program
1
9 0
10 5
11 3

About Vladimir Andelkovic

Vladimir Andelkovic is a scholar working on Toxicology, Oncology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 93 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (2 papers), CAR-T cell therapy research (2 papers) and Soft tissue tumor case studies (2 papers). The work is most often cited by research in Oncology (46 citations), Pulmonary and Respiratory Medicine (55 citations) and Pathology and Forensic Medicine (20 citations). Vladimir Andelkovic has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Rahul Ladwa, Connor O’Leary, Nick Pavlakis, Fred R. Hirsch, Derek J. Richard, Kenneth J. O’Byrne, Caicun Zhou, Balu Bhaskar, Jeremy Lewin and Bernd Kasper. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026